Literature DB >> 32193943

Outcome of inter-hospital transfer versus direct admission for primary percutaneous coronary intervention: An observational study of 25,315 patients with ST-elevation myocardial infarction from the London Heart Attack Group.

Krishnaraj S Rathod1, Ajay K Jain1, Sam Firoozi2, Pitt Lim2, Richard Boyle2, Jo Nevett3, Miles C Dalby4, Sundeep Kalra5, Iqbal S Malik6, Alexander Sirker1, Anthony Mathur1, Simon Redwood7, Philip A MacCarthy8, Andrew Wragg1, Daniel A Jones1.   

Abstract

BACKGROUND AND AIMS: In patients with ST-segment elevation myocardial infarction (STEMI), mortality is directly related to time to reperfusion with guidelines recommending patients be delivered directly to centres for primary percutaneous coronary intervention (PCI). The aim of this study was to describe the impact of inter-hospital transfer on reperfusion time and to assess whether or not treatment delays influenced clinical outcomes in comparison with direct admission to a primary PCI centre in a large regional network. METHOD AND
RESULTS: We undertook an observational cohort study of patients with STEMI treated with primary PCI between 2005 and 2015 in London, UK. Patient details were recorded at the time of the procedure in databases using the British Cardiovascular Intervention Society PCI dataset. The primary end-point was all-cause mortality at a median of 4.1 years (interquartile range: 2.2-5.8 years). Secondary outcomes were in-hospital major adverse cardiac events. Of 25,315 patients, 17,560 (69.4%) were admitted directly to a primary PCI centre and 7755 (31.6%) were transferred from a non-primary PCI centre. Patients in the direct admission group were older and more likely to have left ventricular impairment compared with the inter-hospital transfer group. Median time from call for help to reperfusion in transferred patients was 52 minutes longer compared with patients admitted directly (p <0.001). However, call to first hospital admission was similar. Kaplan-Meier analysis demonstrated significantly lower mortality rates in patients who were transferred directed to a primary PCI centre compared with patients who were transferred from a non-PCI centre (17.4% direct vs. 18.7% transfer, p=0.017). Furthermore, after propensity matching, direct admission for primary PCI was still a predictor of all-cause mortality (hazard ratio: 0.89, 95% confidence interval: 0.64-0.95).
CONCLUSIONS: In this large registry of over 25,000 STEMI patients treated by primary PCI survival was better in patients admitted directly to a cardiac centre versus patients transferred for primary PCI, most likely due to longer call to balloon times in patient transferred from other hospitals.

Entities:  

Keywords:  Primary PCI; direct; myocardial infarction; transfer

Mesh:

Year:  2020        PMID: 32193943     DOI: 10.1177/2048872619882340

Source DB:  PubMed          Journal:  Eur Heart J Acute Cardiovasc Care        ISSN: 2048-8726


  3 in total

1.  Efficacy of comprehensive remote ischemic conditioning in elderly patients with acute ST-segment elevation myocardial infarction underwent primary percutaneous coronary intervention.

Authors:  Yan-Ling Wang; Qi Yang; Cheng-Yan Hu; Yan-Yan Chu; Zheng Sun; Huan Zhao; Zhi Liu
Journal:  J Geriatr Cardiol       Date:  2022-06-28       Impact factor: 3.189

2.  Indirect Transfer to Catheterization Laboratory for ST Elevation Myocardial Infarction Is Associated With Mortality Independent of System Delays: Insights From the France-PCI Registry.

Authors:  Farzin Beygui; Vincent Roule; Fabrice Ivanes; Thierry Dechery; Olivier Bizeau; Laurent Roussel; Philippe Dequenne; Marc-Antoine Arnould; Nicolas Combaret; Jean Philippe Collet; Philippe Commeau; Guillaume Cayla; Gilles Montalescot; Hakim Benamer; Pascal Motreff; Denis Angoulvant; Pierre Marcollet; Stephan Chassaing; Katrien Blanchart; René Koning; Grégoire Rangé
Journal:  Front Cardiovasc Med       Date:  2022-03-11

3.  Reperfusion Strategy of ST-Elevation Myocardial Infarction: A Meta-Analysis of Primary Percutaneous Coronary Intervention and Pharmaco-Invasive Therapy.

Authors:  Kaiyin Li; Bin Zhang; Bo Zheng; Yan Zhang; Yong Huo
Journal:  Front Cardiovasc Med       Date:  2022-03-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.